Kleinke J D
Health Aff (Millwood). 1998 Mar-Apr;17(2):7-26. doi: 10.1377/hlthaff.17.2.7.
Every issue raised by the current investigation into the business practices of Columbia/HCA serves as a signpost for the progress and problems inherent in market-driven health care reform. Actions against Columbia/HCA by regulators reveal deeply rooted resistance to the profit-motivated reforms embodied in the company's philosophy: the public's reluctance to accept necessary reductions in excess hospital capacity; the legal and cultural obstacles to the overdue alignment of physician and hospital economic interests; and the myriad reimbursement and accounting problems involved in the vertical integration of health care delivery. The investigation also underscores the antiquation of the reimbursement mechanisms and control systems in place for financing the delivery of care to Medicare beneficiaries.
当前对哥伦比亚/HCA医疗业务行为展开调查所引发的每一个问题,都标志着市场驱动型医疗改革所固有的进展与问题。监管机构针对哥伦比亚/HCA采取的行动,揭示了对该公司理念中所体现的逐利性改革存在的根深蒂固的抵制:公众不愿接受对过剩医院产能进行必要削减;医生与医院经济利益的适时调整存在法律和文化障碍;以及医疗服务垂直整合中涉及的众多报销和会计问题。此次调查还凸显了为向医疗保险受益人提供医疗服务筹资而现行的报销机制和控制系统的陈旧过时。